Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry-Reference-Cited by-同舟云学术

Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry

Published:2016-09-21 Issue:7 Volume:89 Page:E217-E225
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Chandrasekhar Jaya¹,Bansilal Sameer¹,Baber Usman¹,Sartori Samantha¹,Aquino Melissa¹,Farhan Serdar¹,Vogel Birgit¹,Faggioni Michela¹,Giustino Gennaro¹,Ariti Cono²,Colombo Antonio³,Chieffo Alaide³,Kini Annapoorna¹,Saporito Richard¹,Michael Gibson C.⁴,Witzenbichler Bernhard⁵,Cohen David⁶,Moliterno David⁷,Stuckey Thomas⁸,Henry Timothy⁹,Pocock Stuart²,Dangas George¹,Gabriel Steg P.¹⁰,Mehran Roxana¹

Affiliation:

1. Icahn School of Medicine at Mount Sinai; New York New York

2. London School of Hygiene and Tropical Medicine; London United Kingdom

3. San Raffaele Hospital; Milan Italy

4. Harvard Medical School; Cambridge Massachusetts

5. Helios Amper-Klinikum; Dachau Germany

6. St Luke's Mid America Heart Institute, University of Missouri-Kansas City; Kansas City Missouri

7. University of Kentucky; Lexington Kentucky

8. Moses Cone Heart and Vascular Center, LeBauer Cardiovascular Research Foundation; Greensboro North Carolina

9. Cedars-Sinai Medical Center; Los Angeles

10. Hôpital Bichat-Claude Bernard; Paris France

Funder

Bristol-Myers Squibb and Sanofi-Aventis (to PARIS study)

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Reference27 articles.

1. Cytochrome p-450 polymorphisms and response to clopidogrel;Mega;N Engl J Med,2009

2. Administration, FaD Diminished Antiplatelet Activity Due to Impaired CYP2C19 Function 2010 http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm225843.htm

3. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials;Dunn;J Am Heart Assoc,2013

4. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial;Goodman;Circulation,2012

5. Clopidogrel with or without omeprazole in coronary artery disease;Bhatt;N Engl J Med,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis;BMC Cardiovascular Disorders;2024-07-17

2. The Management and Antithrombotic Strategies of Patients with Coronary Artery Disease and High Bleeding Risk;Current Cardiology Reports;2023-06-07

3. Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-01-10

4. Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines;Cureus;2022-02-03

5. Systematic Review and Meta-analysis: The Effects of Prophylactic Proton Pump Inhibitor Treatment in Patients With Coronary Heart Disease Receiving Dual Antiplatelet Therapy;Journal of Cardiovascular Pharmacology;2021-06